Formulated with 10.56% pharmaceutical-grade lidocaine, this medical-grade topical anesthetic achieves dermal analgesia within 10-12 minutes of occlusion, maintaining therapeutic efficacy for 90±15 minutes. Clinically validated for cosmetic interventions including laser resurfacing (up to 1064nm wavelength), microneedling (0.5-3mm depth), and dermal filler administration.

CLINICAL ADVANTAGES

DERMATOLOGICAL PROTOCOL

PHARMACEUTICAL SPECIFICATIONS

*Anesthetic efficacy varies by skin type (Fitzpatrick II-VI) and procedure depth. Clinical studies show 92% pain reduction in ablative procedures vs. placebo (n=150). Always perform neural sensitivity test prior to full application. Not FDA-evaluated for ocular/nasal use.